Angelique Van Ombergen: Joint ESA/NASA Request for Information on Venous Thrombosis in Space
Angelique Van Ombergen, Chief Exploration Scientist at European Space Agency, shared Hayley Emma Arron‘s post on LinkedIn, adding:
“Joint ESA/NASA Request for Information (RFI) on venous thrombosis in space open now!
Submit your ideas by the deadline of 15th of April 2026 via the link below.”
Hayley Emma Arron, Research Fellow at the European Space Agency, shared a post on LinkedIn:
“Venous Thrombosis RFI – March 2026
ESA and NASA have released a Request for Information (RFI) to support planning and future acquisition strategies related to venous thrombosis (VT) in spaceflight and exploration missions.
The agencies are seeking input on approaches to:
- Monitor VT
- Reduce associated risks
- Develop potential treatment strategies
Contributions may also include recommendations for future spaceflight and analogue research relevant to VT.
All information provided will be used on a non-attribution basis to inform ongoing planning efforts.
Submission deadline: 15 April 2026 (23:59 CET)
If your work aligns with these areas, this is an opportunity to help inform the future direction of human spaceflight health initiatives.”
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 16:22Shannon Farmer: Driving Patient Blood Management Forward in Australia and New Zealand
-
Oct 16, 2026, 16:01Obi Light Ogbonnia: The Greatest Reward Is Changing Lives, Not Winning Awards
-
Oct 16, 2026, 15:18Carmine Liberatore: Limited Accuracy of VTE Risk Scores in Multiple Myeloma
-
Oct 16, 2026, 14:55Alex Borstein and the Bleeding Phenotype of Hemophilia A Carriers
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A